Piboserod
http://dbpedia.org/resource/Piboserod an entity of type: Thing
Piboserod is a selective 5-HT4 receptor antagonist which was marketed and manufactured by GlaxoSmithKline (GSK) under the trade name Serlipet for the management of atrial fibrillation and irritable bowel syndrome. In 2007 the Norwegian company Bio-Medisinsk Innovasjon AS (BMI) completed a clinical phase II study to investigate the effect of piboserod in patients with chronic heart failure.
rdf:langString
rdf:langString
Piboserod
xsd:integer
18861000
xsd:integer
1102283665
rdf:langString
none
xsd:integer
22
xsd:integer
152811
xsd:integer
356359
xsd:integer
154413
xsd:integer
31
rdf:langString
N--3,4-dihydro-2H-oxazinoindole-10-carboxamide
rdf:langString
Clinical phase II
xsd:integer
3
xsd:integer
2
xsd:integer
177336
rdf:langString
Oral
rdf:langString
CCCCN1CCCCC1
xsd:integer
1
rdf:langString
KVCSJPATKXABRQ-UHFFFAOYSA-N
rdf:langString
Serlipet
xsd:integer
4
rdf:langString
changed
xsd:integer
408035930
rdf:langString
changed
rdf:langString
Piboserod is a selective 5-HT4 receptor antagonist which was marketed and manufactured by GlaxoSmithKline (GSK) under the trade name Serlipet for the management of atrial fibrillation and irritable bowel syndrome. In 2007 the Norwegian company Bio-Medisinsk Innovasjon AS (BMI) completed a clinical phase II study to investigate the effect of piboserod in patients with chronic heart failure.
xsd:integer
225
xsd:nonNegativeInteger
3539
rdf:langString
Serlipet
xsd:string
152811-62-6
xsd:string
356359
xsd:string
4UQ3S81B25
xsd:string
177336